Alzheimer’s disease is commonly diagnosed by positron emission tomography scans, with 85% accuracy. However, few patients are tested because the scans are costly and require injection of a radioactive drug. So what if a simple eye exam could detect the disease?

Researchers at Massachusetts General Hospital and Brigham and Women’s Hospital are studying a retina camera and accompanying software to find if it can identify amyloid plaques in the back of the eye that could indicate Alzheimer’s disease. Unlike the injections, the eye exam would be…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Oct 14, 2019

AAO 2019: Positive Efficacy Data Presented for Trial of hRPC Stem Cell Therapy

ReNeuron announced at the AAO 2019 meeting positive clinical data for its Phase 1/2a clinical trial of hRPC stem cell therapy for retinitis pigmentosa.

The ongoing trial is an open-label study to evaluate the safety, tolerability, and efficacy of…

Journal Scan

  1. Oct 02, 2019

Can Dark Chocolate Benefit Visual Function and Retinal Perfusion?

After reports from a previous randomized clinical trial reporting vasodilating flavanols in dark chocolate benefit visual function, a new study assessed the effects of dark chocolate flavanols on subjective visual function and retinal perfusion using optical coherence…